EA200000929A3 - Новые цианоиндольные соединения-ингибиторы повторного захвата серотонина, способ их получения и содержащие их фармацевтические композиции - Google Patents

Новые цианоиндольные соединения-ингибиторы повторного захвата серотонина, способ их получения и содержащие их фармацевтические композиции

Info

Publication number
EA200000929A3
EA200000929A3 EA200000929A EA200000929A EA200000929A3 EA 200000929 A3 EA200000929 A3 EA 200000929A3 EA 200000929 A EA200000929 A EA 200000929A EA 200000929 A EA200000929 A EA 200000929A EA 200000929 A3 EA200000929 A3 EA 200000929A3
Authority
EA
Eurasian Patent Office
Prior art keywords
group
nitrogen
atom
independently
optionally substituted
Prior art date
Application number
EA200000929A
Other languages
English (en)
Other versions
EA200000929A2 (ru
EA003831B1 (ru
Inventor
Жильбер Лявьелль
Оливье Мюллер
Марк Миллан
Дидье Кюссак
Анн Декейн
Original Assignee
Адир Э Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Адир Э Компани filed Critical Адир Э Компани
Publication of EA200000929A2 publication Critical patent/EA200000929A2/ru
Publication of EA200000929A3 publication Critical patent/EA200000929A3/ru
Publication of EA003831B1 publication Critical patent/EA003831B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Соединения формулы (I)в которой Rи R, каждый независимо друг от друга, представляет собой атом водорода или алкильную группу,Tи Т, каждый независимо друг от друга, представляет собой алкиленовую группу,G представляет собой гетероциклическую группу формулы (α) или (β)в которых W-Wи X-Xвыбраны таким образом, чтобы образовалась химически стабильная группа, и имеют следующие значенияW, Wи W, каждый независимо друг от друга, представляет собой атом азота или группу CR, NRили СО,Wпредставляет собой атом азота или группу CR, NRили СО,Wпредставляет собой атом углерода или азота,Xпредставляет собой связь, атом азота или группу CRили NR,Х-Х, каждый независимо друг от друга, представляет собой группу CR, NR, СО, SRили SOлибо атомы кислорода, серы или азота,Rпредставляет собой водород или атом галогена либо алкильную, гидроксильную, пергалоалкильную, нитро, либо необязательно замещенную аминогруппу,Rпредставляет собой атом водорода или алкильную группу, необязательно замещенную арильную группу или необязательно замещенную арилалкильную группу,Rпредставляет собой группу R, либо две соседние группы R, совместно с соединенными с ними атомами углерода, образуют насыщенную, частично ненасыщенную или ненасыщенную моно- или бициклическую труппу, необязательно содержащую от 1 до 5 гетероатомов, выбранных из азота, кислорода и серы, причем указанная группа необязательно замещена одной или более группами, выбранными из Rили оксо.Фармацевтические композиции.
EA200000929A 1999-10-12 2000-10-11 Цианоиндольные соединения-ингибиторы повторного захвата серотонина, способ их получения и содержащие их фармацевтические композиции EA003831B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9912668A FR2799463B1 (fr) 1999-10-12 1999-10-12 Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
EA200000929A2 EA200000929A2 (ru) 2001-04-23
EA200000929A3 true EA200000929A3 (ru) 2001-06-25
EA003831B1 EA003831B1 (ru) 2003-10-30

Family

ID=9550799

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000929A EA003831B1 (ru) 1999-10-12 2000-10-11 Цианоиндольные соединения-ингибиторы повторного захвата серотонина, способ их получения и содержащие их фармацевтические композиции

Country Status (23)

Country Link
US (1) US6492366B1 (ru)
EP (1) EP1092715B1 (ru)
JP (1) JP3274454B2 (ru)
KR (1) KR100470692B1 (ru)
CN (1) CN1146568C (ru)
AT (1) ATE291577T1 (ru)
AU (1) AU774741B2 (ru)
BR (1) BR0004764A (ru)
CA (1) CA2323703C (ru)
DE (1) DE60018869T2 (ru)
DK (1) DK1092715T3 (ru)
EA (1) EA003831B1 (ru)
ES (1) ES2238260T3 (ru)
FR (1) FR2799463B1 (ru)
HK (1) HK1036062A1 (ru)
HU (1) HUP0003991A2 (ru)
MX (1) MXPA00009642A (ru)
NO (1) NO321242B1 (ru)
NZ (1) NZ507458A (ru)
PL (1) PL343148A1 (ru)
PT (1) PT1092715E (ru)
SI (1) SI1092715T1 (ru)
ZA (1) ZA200005625B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693202B1 (en) 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
US7041683B2 (en) 2001-04-24 2006-05-09 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan
US6559169B2 (en) 2001-04-24 2003-05-06 Wyeth Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-benzodioxan
US7276603B2 (en) * 2003-05-02 2007-10-02 Wyeth Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
WO2005113833A2 (en) * 2004-05-21 2005-12-01 Duke University Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis
EP2629615B1 (en) 2010-10-22 2018-10-10 Duke University Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2043709C (en) * 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives
RO111767B1 (ro) * 1990-10-15 1997-01-30 Pfizer Derivati de indol, procedee si intermediari pentru prepararea acestora, compozitii farmaceutice si metoda pentru tratarea unor afectiuni
GB9208161D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Indoles
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
IT1271352B (it) * 1993-04-08 1997-05-27 Boehringer Ingelheim Italia Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
ES2079323B1 (es) * 1994-06-21 1996-10-16 Vita Invest Sa Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
WO1996001865A1 (en) * 1994-07-11 1996-01-25 Dsm N.V. Multihydroxy-functional oligophenylene oxide
AR004229A1 (es) * 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5998462A (en) * 1996-12-16 1999-12-07 Allelix Biopharmaceuticals Inc. 5-alkyl indole compounds

Also Published As

Publication number Publication date
HK1036062A1 (en) 2001-12-21
EP1092715B1 (fr) 2005-03-23
EA200000929A2 (ru) 2001-04-23
US6492366B1 (en) 2002-12-10
HU0003991D0 (en) 2000-12-28
JP3274454B2 (ja) 2002-04-15
SI1092715T1 (en) 2005-06-30
FR2799463A1 (fr) 2001-04-13
DE60018869D1 (de) 2005-04-28
NO20005103D0 (no) 2000-10-10
CA2323703A1 (fr) 2001-04-12
NZ507458A (en) 2002-03-28
CN1146568C (zh) 2004-04-21
KR100470692B1 (ko) 2005-03-07
MXPA00009642A (es) 2002-05-23
HUP0003991A2 (en) 2002-06-29
NO20005103L (no) 2001-04-17
DE60018869T2 (de) 2006-02-02
ZA200005625B (en) 2001-05-02
NO321242B1 (no) 2006-04-10
FR2799463B1 (fr) 2004-04-16
DK1092715T3 (da) 2005-07-25
AU6547900A (en) 2001-04-26
JP2001151772A (ja) 2001-06-05
KR20010050984A (ko) 2001-06-25
PT1092715E (pt) 2005-06-30
EP1092715A2 (fr) 2001-04-18
EA003831B1 (ru) 2003-10-30
BR0004764A (pt) 2001-05-29
ES2238260T3 (es) 2005-09-01
CN1296010A (zh) 2001-05-23
ATE291577T1 (de) 2005-04-15
CA2323703C (fr) 2005-08-16
PL343148A1 (en) 2001-04-23
EP1092715A3 (fr) 2001-08-08
AU774741B2 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
IL160304A (en) Compounds and composition for activating peroxisome proliferators-responsive receptor ??
YU53700A (sh) Biciklo(2.2.1.) heptani i srodna jedinjenja
CA2318579A1 (en) Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
ES8307231A1 (es) Procedimiento para preparar derivados de piridona.
UA41875C2 (ru) Способ ингибирования эстроген-зависимых опухолей с применением стероидных сульфатсодержащих ингибиторов
NZ518144A (en) Piperazine Compounds
DE60027131D1 (de) Inhibitoren für asparagin-proteasen
DE3462250D1 (en) Thioethers, process for their preparation and medicines containing these compounds
EA200000929A3 (ru) Новые цианоиндольные соединения-ингибиторы повторного захвата серотонина, способ их получения и содержащие их фармацевтические композиции
BR0002448A (pt) Ciclopentilalquil-nitrilas
BG105123A (en) Tetrahydroquinaline derivatives as glycine antagonists
WO1998053790A3 (en) Compounds that inhibit the binding of vascular endothelial growth factor to its receptors
MEP12108A (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
SE8303913L (sv) Heterocykliska foreningar
PE20011003A1 (es) Inhibidores de metaloproteasas
BR9813923A (pt) N n - bis(sulfonil) hidrazinas úteis como agentes antineoplásicos
NZ228091A (en) Substituted hydrazones and fungicidal compositions
EA200001107A1 (ru) ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ
DK0504290T3 (da) Inhibitorer af dihydrofylatreduktase fra Pneumocystis carinii
ATE27455T1 (de) Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
BG101287A (en) Microbicidal composition
ES2183500T3 (es) Nuevos compuestos y composiciones farmaceuticas que los contienen.
ES556048A0 (es) Un procedimiento para la preparacion de un derivado de tiazolidina.
EA200000373A2 (ru) Новые соединения 1-аза-2-алкил-6-арилциклоалкана, способ их получения и содержащие их фармацевтические композиции
MY132324A (en) New piperazine derivatives and methods for the preperation thereof and compositions containing the same

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU